Acronym: CFAR

(Cytoxan®, Neosar®)

Cancers treated with cyclophosphamide include: Hodgkin’s and non-Hodgkin's lymphoma, Burkitt’s lymphoma, chronic lymphocytic leukemia (CLL), chronic myelocytic leukemia (CML), acute myelocytic leukemia (AML), acute lymphocytic leukemia (ALL), t-cell lymphoma (mycosis fungoides), multiple myeloma, neuroblastoma, retinoblastoma, rhabdomyosarcoma, Ewing's sarcoma; breast, testicular, endometrial, ovarian, and lung cancers, and in conditioning regimens for bone marrow transplantation.

(Fludara)

Treatment of chronic lymphocytic leukemia (CLL), including CLL that has not responded to or reoccurred after standard therapy.

Salvage therapy for non-Hodgkin's lymphoma and acute leukemias.

(Campath®)

Used to treat B-cell chronic lymphocytic leukemia (CLL)

This drug is administered by infusion into a vein (intravenous, IV).

Alemtuzumab is a monoclonal antibody.

(Rituxan®)

Treatment of certain types of non-Hodgkin's lymphoma.

Treatment of chronic lymphocytic leukemia (CLL).